PresentationbyKaranAnejaAileenDeSoto.pptVIP

Agenda Background The Technology and Patents The Case The Result Questions Company Background Medical device corporation and pioneer in innovative devices and products for interventional vascular medicine and electrophysiology CYPHER drug-eluting stent Drug-eluting Stents Used in Coronary Angioplasty to reduce restenosis Cordis CYPHER sirolimus-eluting stent approval – 2003 BSC TAXUS paclitaxel-eluting stent approval - 2004? Over?one million placed in 2004. History – BCS TAXUS vs. Cordis CYPHER Started in 2000 June 2005 – Delaware Netherlands Cordis vs. BSC - TAXUS stent infringing History – August 2007 6 Patents involved 4 Kasterhofer patents 1 Forman patent 1 related to Forman - dropped from case Cordis responds – 5 motions Kastenhofer patents invalid for failure to satisfy the Written Description requirements Kastenhofer patents invalid for Obviousness Forman Patent is invalid for Obviousness Forman Patent is Not Infringed Limit BSCs Damage claims Patents: Gerhard Kastenhofer 3 device patents (5,843,032, 6,027,477, 6,471,673) and 1 method patent (5,961,765) 3 device patents very similar. All patents contained the same abstract and similar claims to one another. An interventional catheter is a tube used during angioplasty that contains 2 layers of superposed material. The inner layer has low friction coefficient(which prevents the guide wire to get clogged), while the outer layer has a higher friction of coefficient. The balloon is on the placed on the catheter tube which allows for the surrounding catheter tube to expand. The method claim dealt with the actual process of making the catheter itself. The patents is a step by step process that gives a detailed description of how to build the catheter in order to fulfill the device claims for the other 3 device patents. Catheter Patent: Michael R. Foreman Two patents, but one thrown out because too related to other patents. Both of Foreman’s patents dealt with